| Active ingredients | Status | Update | Specialty |
| opium (powder), paracetamol] | Supply tension | 16/01/2026 | Izalgi 500 mg/25 mg, capsule |
| bendamustine (hydrochloride) monohydrate] | Supply tension | 16/01/2026 | Bendamustine Hikma 2.5 mg/mL, powder for solution for infusion |
| ascorbic acid] | Return to availability | 16/01/2026 | Laroscorbine 1 g/5 mL, IV injectable solution in ampoule |
| iomeprol] | Supply tension | 15/01/2026 | Ioméron 250, 350, and 400 mg iodine/mL, injectable solution in 50, 100, 200, and 500 mL – |
| Return to availability | 15/01/2026 | Boostrix Tetra, suspension for injection in a pre-filled syringe. Diphtheria, tetanus, pertussis (acellular multicomponent) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen content) | |
| Supply tension | 15/01/2026 | Repevax, suspension for injection in a pre-filled syringe. Diphtheria, tetanus, pertussis (acellular, multi-component) and poliomyelitis (inactivated) vaccine, (adsorbed, reduced antigen content). | |
| ifosfamide] | Stock shortage | 15/01/2026 | Holoxan 1000 mg, powder for solution for injection, and 2000 mg, powder for parenteral use |
| methylphenidate (hydrochloride)] | Supply tension | 14/01/2026 | Methylphenidate EG LP, extended-release tablet |
| olipudase alfa] | Supply tension | 14/01/2026 | Xenpozyme 20 mg, powder for solution for infusion |
| aztreonam] | Stock shortage | 12/01/2026 | Azactam 1 g, powder and solution for parenteral use |
| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Mecvitazine | Primaran Tablets (Mecuitazine) | Na-jeong | Supply Discontinuation | 2026-01-15 |
| Vinblastine Sulfate | Belvastin Injection (Vinblastine Sulfate) | Freeze-Dried Powder for Solution for Injection | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection (Dacarbazine) (Export Name: DTIC-VHB for injection 100mg) | Freeze-Dried Powder for Solution for Injection | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection 200 Milligrams (Dacarbazine) (Export Name: DTIC-VHB for injection, Duticin for injection) | Freeze-Dried Powder for Solution for Injection | Supply Discontinuation | 2026-01-15 |
| Dilazep Hydrochloride Hydrate | Bukwang Comelian Tablets 50mg (Dilazep Hydrochloride Hydrate) | Film-coated tablet | Supply Discontinuation | 2026-01-15 |
| Deferasirox | Exzide Film-Coated Tablets 180 milligrams (Deferasirox) | Film-coated tablet | Supply Shortage | 2026-01-14 |
| Dexketoprofen Trometamol | Keral Injection (Dexketoprofen Trometamol) | Solution for Injection | Supply Discontinuation | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 40 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 10 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 20 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 80mg (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Active ingredients | Message type | Date of last message | Type of reason | AM designation |
| Metformin hydrochloride | Change notification | 16.01.2026 | Other | Metformin 500 – 1 A Pharma |
| Pramipexole dihydrochloride monohydrate | Change notification | 16.01.2026 | Other | Pramipexole – 1 A Pharma 0.26 mg prolonged-release tablets |
| Alprazolam | Change notification | 16.01.2026 | Other | Alprazolam – 1 A Pharma 0.5 mg tablets |
| Tetrabenazine | Change notification | 16.01.2026 | Other | Tetrabenazine Aristo 25 mg tablets |
| Tamoxifen citrate | Change notification | 16.01.2026 | Production problem | Tamoxifen Aristo 10 mg tablets |
| Nitrendipine | Change notification | 16.01.2026 | Production problem | Nitrendipine Aristo 20 mg film-coated tablets |
| Von Willebrand factor | Change notification | 16.01.2026 | Other | WILLFACT 1000 I.U. |
| Calcium acetate; heavy, basic magnesium carbonate | Change notification | 16.01.2026 | Production problem | OsvaRen |
| Methyldopa (Ph.Eur.) | Initial report | 16.01.2026 | Other | Dopegyt tablets |
| Rifampicin sodium | Change notification | 16.01.2026 | Other | Eremfat i.v. 600mg |
| Lorazepam | Change notification | 15.01.2026 | Other | Tavor 2.5 mg Expidet |
| Insulin aspart | Initial report | 15.01.2026 | Production problem | Fiasp 100 units/ml solution for injection in pre-filled pen – OP10[2x(5x3ml)] |
| Clonidine hydrochloride | Change notification | 15.01.2026 | Other | Clonidine-ratiopharm 75 |
| Clonidine hydrochloride | Change notification | 15.01.2026 | Other | Clonidine-ratiopharm 150 |
| Clonidine hydrochloride | Change notification | 15.01.2026 | Other | Clonidine-ratiopharm 300 |
| Sufentanil citrate | Change notification | 15.01.2026 | Production problem | Sufenta mite |
| Naloxone hydrochloride dihydrate; oxycodone hydrochloride (Ph.Eur.) | Initial report | 15.01.2026 | Production problem | Targin 40 mg/20 mg prolonged-release tablets |
| Primidone | Change notification | 15.01.2026 | Production problem | Mylepsinum |
| Buprenorphine | Change notification | 15.01.2026 | Other | Buprenorphine AWD Matrix 70 micrograms/h Transdermal patch |
| Buprenorphine | Change notification | 15.01.2026 | Other | Buprenorphine AWD Matrix 52.5 micrograms/h Transdermal patch |
| Colistimethate sodium | Change notification | 15.01.2026 | Production problem | Colistin CF |
| Ipratropium bromide (Ph.Eur.) | Change notification | 15.01.2026 | Production problem | Ipratropium Teva 250 micrograms/1 ml solution for nebulizer |
| Nitrendipine | Change notification | 15.01.2026 | Other | Nitrendipine AbZ 20 mg tablets |
| Nitrendipine | Change notification | 15.01.2026 | Other | Nitrendipine-ratiopharm 10 mg tablets |
| Buprenorphine | Change notification | 15.01.2026 | Other | Buprenorphine-ratiopharm 35 micrograms/h transdermal patch |
| Buprenorphine | Change notification | 15.01.2026 | Other | Buprenorphine-ratiopharm 52.5 micrograms/h transdermal patch |
| Buprenorphine | Change notification | 15.01.2026 | Other | Buprenorphine-ratiopharm 70 micrograms/h transdermal patch |
| Everolimus | Change notification | 15.01.2026 | Other | Everolimus-ratiopharm 10 mg tablets |
| Everolimus | Change notification | 15.01.2026 | Other | Everolimus-ratiopharm 2.5 mg tablets |
| Everolimus | Change notification | 15.01.2026 | Other | Everolimus-ratiopharm 5 mg tablets |
| Fibrinogen, human | Change notification | 15.01.2026 | Other | Fibryga |
| Alprazolam | Change notification | 15.01.2026 | Other | Alprazolam-ratiopharm 1.0 mg tablets |
| Nitrendipine | Change notification | 15.01.2026 | Other | Nitrendipine-ratiopharm 20 mg tablets |
| Methylphenidate hydrochloride | Change notification | 14.01.2026 | Other | METHYLPHENIDATE 20 mg tablets |
| Sumatriptan succinate | Initial report | 14.01.2026 | Production problem | MIGRAPEN 3 mg/0.5 ml solution for injection in a pre-filled pen |
| Ipratropium bromide (Ph.Eur.); salbutamol sulfate | Change notification | 14.01.2026 | Production problem | COMBIPRASAL 0.5 mg / 2.5 mg solution for nebulizer |
| Tropicamide | Change notification | 14.01.2026 | Production problem | Mydriaticum Stulln UD |
| Ethambutol dihydrochloride | Initial report | 14.01.2026 | Production problem | EMB-FATOL 400 mg |
| Dinoprostone | Change notification | 14.01.2026 | Production problem | Minprostin E2 vaginal tablets |
| Dinoprostone | Change notification | 14.01.2026 | Other | Minprostin E2 vaginal gel 1mg |
| Dinoprostone | Change notification | 14.01.2026 | Other | Minprostin E2 vaginal gel 2 mg |
| Tacrolimus monohydrate | Change notification | 14.01.2026 | Other | Tacrolimus AL 5 mg hard capsules, delayed release |
| Tacrolimus monohydrate | Change notification | 14.01.2026 | Other | Tacrolimus AL 1 mg hard capsules, delayed release |
| Tacrolimus monohydrate | Change notification | 14.01.2026 | Other | Tacrolimus AL 0.5 mg hard capsules, delayed release |
| Tacrolimus monohydrate | Change notification | 14.01.2026 | Other | Tacrolimus AL 3 mg hard capsules, delayed release |
| Rifampicin | Initial report | 14.01.2026 | Production problem | Eremfat syrup |
| Rifampicin | Initial report | 14.01.2026 | Production problem | EREMFAT 450 mg |
| Alprazolam | Change notification | 14.01.2026 | Other | Alprazolam AbZ 0.5 mg tablets |
| Methylphenidate hydrochloride | Change notification | 14.01.2026 | Other | Methylphenidate hydrochloride-neuraxpharm 27 mg prolonged-release tablets |
| (2-aminoethyl)dihydrogen phosphate calcium salt (1:1) | Change notification | 14.01.2026 | Other | Calcium EAP |
| Sodium (methylprednisolone-21-succinate) | Change notification | 13.01.2026 | Other | Urbason solubile forte 250 mg |
| Sodium (methylprednisolone-21-succinate) | Change notification | 13.01.2026 | Other | Urbason soluble forte 1000 mg |
| Rizatriptan benzoate | Change notification | 13.01.2026 | Other | Rizatriptan PUREN 10 mg tablets |
| Levetiracetam | Initial report | 13.01.2026 | Production problem | Levetiracetam Holsten 750 mg film-coated tablets |
| Levetiracetam | Initial report | 13.01.2026 | Production problem | Levetiracetam Holsten 500 mg film-coated tablets |
| Levetiracetam | Change notification | 13.01.2026 | Production problem | Levetiracetam Holsten 250 mg film-coated tablets |
| Fluphenazine decanoate | Change notification | 13.01.2026 | Production problem | Fluphenazine-neuraxpharm D 100 mg/ml |
| Fluphenazine decanoate | Change notification | 13.01.2026 | Production problem | Fluphenazine-neuraxpharm D 25 mg/ml |
| Fluphenazine decanoate | Change notification | 13.01.2026 | Production problem | Fluphenazine-neuraxpharm D 12.5 mg/0.5 ml |
| Fluphenazine decanoate | Change notification | 13.01.2026 | Production problem | Fluphenazine-neuraxpharm D 50 mg/0.5 ml |
| Clonidine hydrochloride | Initial report | 13.01.2026 | Production problem | Clonistada 0.3 mg tablets |
| Erythromycin | Initial report | 13.01.2026 | Other | Inderm |
| Aprepitant | Change notification | 13.01.2026 | Other | Aprepitant AL 125 mg and 80 mg hard capsules |
| Aprepitant | Change notification | 13.01.2026 | Other | Aprepitant AL 125 mg hard capsules |
| Aprepitant | Change notification | 13.01.2026 | Other | Aprepitant AL 80 mg hard capsules |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 13.01.2026 | Other | Quetiapine AL 50 mg prolonged-release tablets |
| Propranolol hydrochloride | Initial report | 13.01.2026 | Other | DOCITON 80mg |
| Fluoxetine hydrochloride | Change notification | 13.01.2026 | Other | Fluoxetine Micro Labs 60 mg hard capsules |
| Fluoxetine hydrochloride | Change notification | 13.01.2026 | Other | Fluoxetine Micro Labs 30 mg hard capsules |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 13.01.2026 | Other | Atorvastatin Micro Labs 30 mg film-coated tablets |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 13.01.2026 | Other | Atorvastatin Micro Labs 60 mg film-coated tablets |
| Citalopram hydrobromide | Change notification | 13.01.2026 | Production problem | Citalopram STADA 10 mg film-coated tablets |
| Ciprofloxacin sulfate (1:1) | Initial report | 12.01.2026 | Production problem | Ciprofloxacin Kabi 200 mg/100 ml solution for infusion |
| Galantamine hydrobromide | Change notification | 12.01.2026 | Other | Galanaxiro 8 mg hard capsules, delayed release |
| Galantamine hydrobromide | Change notification | 12.01.2026 | Other | Galanaxiro 16 mg hard capsules, delayed release |
| Galantamine hydrobromide | Change notification | 12.01.2026 | Other | Galanaxiro 24 mg hard capsules, delayed release |
| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| topiramate | Tablet, film coated | 25 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 19/01/2026 |
| levetiracetam | Tablet, film coated | 500 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Manufacturing | 19/01/2026 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 4.986 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 19/01/2026 |
| eplerenone | Tablet, film coated | 50 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| eplerenone | Tablet, film coated | 25 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| aprepitant | Capsule | 165 mg | Current | Limited Availability | Manufacturing | 19/01/2026 |
| lamotrigine | Tablet, chewable | 50 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 873.32 mg | Current | Unavailable | Manufacturing | 19/01/2026 |
| terbinafine hydrochloride | Tablet, uncoated | 281.25 mg | Current | Unavailable | Manufacturing | 16/01/2026 |
| salbutamol sulfate | Inhalation | 2.4 mg/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 16/01/2026 |
| donepezil hydrochloride | Tablet, film coated | 5 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| tacrolimus monohydrate | Capsule, hard | 5.112 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| valsartan~hydrochlorothiazide | Tablet, film coated | 160 mg~12.5 mg | Current | Limited Availability | Manufacturing | 16/01/2026 |
| temozolomide | Capsule, hard | 20 mg | Current | Unavailable | Manufacturing | 16/01/2026 |
| entecavir | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 16/01/2026 |
| fenofibrate | Tablet | 48 mg | Anticipated | Available | Manufacturing | 16/01/2026 |
| tobramycin | Inhalation, conventional | 60 mg/mL | Resolved | Available | Manufacturing | 16/01/2026 |
| fingolimod hydrochloride | Capsule | 560 microgram | Current | Unavailable | Manufacturing | 16/01/2026 |
| pentamidine isetionate | Injection, powder for | 300 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| ketorolac trometamol | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 16/01/2026 |
| lanreotide acetate | Injection, solution | 100 mg | Current | Unavailable | Manufacturing | 16/01/2026 |
| lanreotide acetate | Injection, solution | 66.67 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 16/01/2026 |
| nitrofurantoin | Capsule, hard | 100 mg | Current | Unavailable | Unexpected increase in consumer demand | 16/01/2026 |
| nitrofurantoin | Capsule, hard | 50 mg | Current | Limited Availability | Manufacturing | 16/01/2026 |
| hydrocortisone hydrogen succinate | Injection, powder for | 127.6 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| amphotericin B | Injection, powder for | 50 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| tetrabenazine | Tablet, uncoated | 25 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| olipudase alfa | Injection, powder for | 20 mg | Anticipated | Available | Manufacturing | 16/01/2026 |
| olanzapine | Tablet, film coated | 5 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 16/01/2026 |
| atovaquone~proguanil hydrochloride | Tablet, film coated | 62.5 mg~25 mg | Anticipated | Available | Unexpected increase in consumer demand | 16/01/2026 |
| flumetasone pivalate~clioquinol | Ear Drops | .2 mg/mL~10 mg/mL | Anticipated | Available | Commercial Changes / Commercial viability | 15/01/2026 |
| bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 15/01/2026 |
| propofol | Injection, intravenous infusion | 10 mg/mL | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 15/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.256 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| temozolomide | Capsule, hard | 140 mg | Anticipated | Available | Manufacturing | 15/01/2026 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| amlodipine besilate~telmisartan | Tablet, film coated | 13.87 mg~40 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/01/2026 |
| telmisartan~amlodipine besilate | Tablet, film coated | 80 mg~6.935 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/01/2026 |
| telmisartan~amlodipine besilate | Tablet, film coated | 80 mg~13.87 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/01/2026 |
| amlodipine besilate~telmisartan | Tablet, film coated | 6.935 mg~40 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/01/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Limited Availability | Manufacturing | 15/01/2026 |
| betahistine dihydrochloride | Tablet | 16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| moxonidine | Tablet, film coated | 400 microgram | Current | Unavailable | Manufacturing | 15/01/2026 |
| agomelatinecitric acid | Tablet, film coated | 44.739 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 15/01/2026 |
| iopromide | Injection, solution | 768.86 mg/mL | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 15/01/2026 |
| paroxetine hydrochloride | Tablet, film coated | 22.22 mg | Resolved | Available | Manufacturing | 15/01/2026 |
| levothyroxine sodium | Tablet, uncoated | .1 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 15/01/2026 |
| framycetin sulfate | Eye and Ear Drops | 5 mg/mL | Current | Limited Availability | Manufacturing | 15/01/2026 |
| estradiol hemihydrate | Drug delivery system, transdermal | 3.09 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| dinoprostone | Gel | .3333 mg/g | Current | Unavailable | Manufacturing | 15/01/2026 |
| ambrisentan | Tablet, film coated | 5 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 14/01/2026 |
| olanzapine | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 14/01/2026 |
| calcium folinate hydrate | Tablet, uncoated | 18.6 mg | Current | Limited Availability | Unexpected increase in consumer demand | 14/01/2026 |
| carbidopa monohydrate~levodopa~entacapone | Tablet, film coated | 40.5 mg~150 mg~200 mg | Resolved | Available | Unexpected increase in consumer demand | 14/01/2026 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 14/01/2026 |
| posaconazole | Tablet, modified release | 100 mg | Current | Limited Availability | Manufacturing | 14/01/2026 |
| sitagliptin hydrochloride monohydrate~metformin hydrochloride | Tablet, modified release | 56.685 mg~1000 mg | Resolved | Available | Manufacturing | 14/01/2026 |
| prilocaine hydrochloride | Injection, solution | 100 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 14/01/2026 |
| varenicline tartrate~varenicline tartrate | Tablet, film coated | .855 mg~1.71 mg | Resolved | Available | Manufacturing | 14/01/2026 |
| metformin hydrochloride | Tablet, modified release | 1000 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 14/01/2026 |
| cytarabine | Injection, solution | 100 mg/mL | Anticipated | Available | Manufacturing | 14/01/2026 |
| desferrioxamine mesilate | Injection, powder for | 2 g | Current | Limited Availability | Manufacturing | 14/01/2026 |
| betiatide | Injection, powder for | 1 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| acetylcysteine | Injection, concentrated | 2 g | Current | Limited Availability | Manufacturing | 13/01/2026 |
| verapamil hydrochloride | Tablet, film coated | 240 mg | Resolved | Available | Manufacturing | 13/01/2026 |
| venlafaxine | Capsule, modified release | 75 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| ondansetron hydrochloride dihydrate | Injection, solution | 5 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| ondansetron hydrochloride dihydrate | Injection, solution | 10 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Resolved | Available | Manufacturing | 13/01/2026 |
| remifentanil hydrochloride | Injection, powder for | 1.097 mg | Resolved | Available | Manufacturing | 13/01/2026 |
| temozolomide | Capsule, hard | 5 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| lansoprazole | Tablet, orally disintegrating | 30 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 13/01/2026 |
| propofol | Injection, emulsion | 10 mg/mL | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 13/01/2026 |
| fentanyl citrate | Injection, solution | 785 microgram | Discontinued | Unavailable | Commercial Changes / Commercial viability | 13/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Resolved | Available | Unexpected increase in consumer demand | 13/01/2026 |
| atomoxetine hydrochloride | Capsule, hard | 20.57 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| paracetamol | Injection | .5 g | Discontinued | Unavailable | Commercial Changes / Commercial viability | 13/01/2026 |
| paracetamol | Injection | .1 g | Discontinued | Unavailable | Commercial Changes / Commercial viability | 13/01/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| erlotinib hydrochloride | Tablet, film coated | 27.32 mg | Current | Unavailable | Unexpected increase in consumer demand | 13/01/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.751 mg | Resolved | Available | Manufacturing | 13/01/2026 |
| prucalopride succinate | Tablet | 1.321 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| prucalopride succinate | Tablet | 2.642 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| Teriparatide | Injection, solution | 250 microgram/mL | Resolved | Available | Manufacturing | 13/01/2026 |
| doxepin hydrochloride | Capsule, hard | 28.25 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| flunitrazepam | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| bupivacaine hydrochloride monohydrate | Injection, solution | 52.8 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 12/01/2026 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Anticipated | Available | Unexpected increase in consumer demand | 12/01/2026 |
| dantrolene sodium hemiheptahydrate | Injection, powder for | 20 mg | Current | Emergency Supply Only | Manufacturing | 12/01/2026 |
| trimethoprim~sulfamethoxazole | Injection, concentrated | 16 mg/mL~80 mg/mL | Current | Unavailable | Manufacturing | 12/01/2026 |
| midazolam hydrochloride | Injection, solution | 5.56 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 12/01/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| erenumab | Injection, solution | 70 mg | Current | Limited Availability | Unexpected increase in consumer demand | 12/01/2026 |
| ambrisentan | Tablet, film coated | 5 mg | Resolved | Available | Manufacturing | 12/01/2026 |
| ambrisentan | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 12/01/2026 |
| estradiol | Drug delivery system, transdermal | .39 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| estradiol | Drug delivery system, transdermal | .78 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| estradiol | Drug delivery system, transdermal | 1.56 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| Teriparatide | Injection, solution | .25 mg/mL | Anticipated | Available | Manufacturing | 12/01/2026 |
| clindamycin phosphate | Cream | 22.8 mg/g | Anticipated | Available | Unexpected increase in consumer demand | 12/01/2026 |
| Peginterferon alfa2a | Injection, solution | 135 microgram | Current | Unavailable | Manufacturing | 12/01/2026 |
| Peginterferon alfa2a | Injection, solution | 180 microgram | Current | Unavailable | Manufacturing | 12/01/2026 |
| dinoprostone | Gel | .6667 mg/g | Current | Unavailable | Manufacturing | 12/01/2026 |
January 13, 2026
January 12, 2026
January 15, 2026
January 14, 2026
